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 ABSTRACT 
 Research on the use of natural products to treat or 
prevent microbial invasion as alternatives to antibiotic 
use is growing. Polymorphonuclear leukocytes (PMNL) 
play a vital role with regard to the innate immune 
response that affects severity or duration of mastitis. 
To our knowledge, effect of cold-pressed terpeneless 
Valencia orange oil (TCO) on bovine PMNL function 
has not been elucidated. Therefore, the objective of this 
study was to investigate the effect of TCO on bovine 
blood PMNL chemotaxis and phagocytosis capabilities 
and the expression of genes involved in inflammatory 
response in vitro. Polymorphonuclear leukocytes were 
isolated from jugular blood of 12 Holstein cows in mid-
lactation and were incubated with 0.0 or 0.01% TCO 
for 120 min at 37°C and 5% CO2, and phagocytosis (2 
× 106 PMNL) and chemotaxis (6 × 106 PMNL) as-
says were then performed in vitro. For gene expression, 
RNA was extracted from incubated PMNL (6 × 106
PMNL), and gene expression was analyzed using quan-
titative PCR. The supernatant was stored at −80°C for 
analysis of tumor necrosis factor-α. Data were analyzed 
using a general linear mixed model with cow and treat-
ment (i.e., control or TCO) in the model statement. In 
vitro supplementation of 0.01% of TCO increased the 
chemotactic ability to IL-8 by 47%; however, migration 
of PMNL to complement 5a was not altered. Treatment 
did not affect the production of tumor necrosis factor-α 
by PMNL. Expression of proinflammatory genes (i.e., 
SELL, TLR4, IRAK1, TRAF6, and LYZ) coding for 
proteins was not altered by incubation of PMNL with 
TCO. However, downregulation of TLR2 [fold change 
(FC = treatment/control) = −2.14], NFKBIA (FC = 
1.82), IL1B (FC = −2.16), TNFA (FC = −9.43), and 
SOD2 (FC = −1.57) was observed for PMNL incubated 
with TCO when compared with controls. Interestingly, 
expression of IL10, a well-known antiinflammatory cy-
tokine, was also downregulated (FC = −3.78), whereas 
expression of IL8 (FC = 1.93), a gene coding for the cy-
tokine IL-8 known for its chemotactic function, tended 
to be upregulated in PMNL incubated with TCO. In-
cubation of PMNL with TCO enhanced PMNL chemo-
taxis in vitro. The expression of genes involved in the 
inflammatory response was primarily downregulated. 
Results showed that 0.01% TCO did not impair the 
function of PMNL in vitro. Future studies investigating 
the use of TCO as an alternative therapy for treatment 
of mastitis, including dose and duration, for cows dur-
ing lactation are warranted. 
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 INTRODUCTION 
 The economic losses due to mastitis in the United 
States exceed $2 billion annually (Nickerson and 
Oliver, 2014). Mastitis, an inflammation of the mam-
mary gland, is usually associated with the presence of 
a pathogen such as Escherichia coli, Klebsiella spp., 
Streptococcus spp., and Staphylococcus spp. (Kehrli and 
Shuster, 1994). During mastitis, circulating neutro-
phils, also known as PMNL, are of key importance in 
controlling the severity and duration of mastitis (Bur-
venich et al., 2007). During inflammation, PMNL are 
the most predominant cell type in the mammary gland, 
accounting for approximately 95% of somatic cell popu-
lation (Kehrli and Shuster, 1994), and are, therefore, 
of critical importance for resolution of mastitis. Anti-
biotics to treat mastitis have been extensively used in 
the past 60 yr (Plastridge, 1958). However, growing 
consumer concerns regarding antibiotic use have led to 
the examination of alternative strategies for controlling 
mastitis while reducing the use of antibiotics on-farm 
(Bannantine et al., 2013). 
 Citrus oils, or fractions thereof, have been tradi-
tionally used as flavoring agents in foods, and it has 
frequently been noted that many possess antimicrobial 
properties (Smith-Palmer et al., 1998; Alzoreky and Na-
kahara, 2003; Muthaiyan et al., 2012a,b). Citrus essen-
tial oils have been part of the human diet for hundreds 
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of years. Therapeutic use of a variety of essential oils 
as either individual compounds or mixtures has been 
satisfactorily evaluated to inhibit the activity (growth 
inhibition) of Staphylococcus strains and E. coli (Fratini 
et al., 2014). Citrus essential oils are complex mixtures 
of volatile and nonvolatile compounds. The volatile 
compounds are a mixture of monoterpene and sesqui-
terpene hydrocarbons and their oxygenated derivatives 
(Fisher and Phillips, 2008). Removal of the terpene 
fraction from essential oils, which are readily oxidized 
when exposed to air, is performed by fractional distilla-
tion, by extraction of the oxygenated compounds with 
diluted alcohol or other solvents, or by combination of 
these methods resulting in significant reduction of the 
limonene fraction (Kirchner and Miller, 1952). Studies 
evaluating the therapeutic use of citrus essential oils in 
ruminants are very limited and are more focused on its 
antibacterial effect in reducing pathogen population in 
feces (Jacob et al., 2009; Callaway et al., 2011).
Cold-pressed terpeneless Valencia orange oil (TCO) 
contains limited amounts of the essential-oil limonene 
(0.3%) and is rich in linalool (20.2%), decanal (18%), 
and geranial (9.1%; Nannapaneni et al., 2009). This 
product is more stable and contains most of the odor 
and flavor of the original oil (Kirchner and Miller, 1952). 
Several in vitro studies, using different concentrations 
of TCO, reported that TCO inhibits the growth of a 
wide range of microbes such as Mycobacterium tubercu-
losis and Mycobacterium bovis (Crandall et al., 2012), 
E. coli O157:H7 (Nannapaneni et al., 2008), Campy-
lobacter jejuni and Campylobacter coli (Nannapaneni 
et al., 2009), Staphylococcus aureus (Muthaiyan et al., 
2012b), and different Listeria strains (Shannon et al., 
2011; Muthaiyan et al., 2012b). Other studies have 
evaluated the antimicrobial effect of TCO on growth 
reduction of C. jejuni and C. coli in retail chicken legs 
and thighs (Nannapaneni et al., 2009), Samonella ssp. 
and E. coli O157:H7 in beef meat (Pittman et al., 2011), 
and Staph. aureus in keratinocytes (Muthaiyan et al., 
2012a). To our knowledge, no study has evaluated the 
effect of TCO as an alternative therapy to control 
mastitis in dairy cows. Because of their vital role in 
controlling mastitis, examining the effect of TCO on 
PMNL function will identify the role of TCO on the 
host response that may affect the severity and duration 
of mastitis. Therefore, the objective of this study was 
to investigate the effect of TCO on bovine blood PMNL 
chemotaxis and phagocytosis capabilities in vitro and 
the expression of genes involved in the inflammatory 
response of PMNL. Results will identify the effect of 
TCO on PMNL inflammatory response and advance 
our knowledge regarding its potential use as an alterna-
tive therapy for mastitis in dairy cows.
MATERIALS AND METHODS
Animals
All procedures involving the use of live animals were 
approved in accordance with the regulations and guide-
lines set forth by the USDA Beltsville Animal Care and 
Use Committee. Twelve Holstein cows in mid-lactation 
(129 ± 22 DIM; 7 primiparous and 5 multiparous) were 
used for this study. All cows were free of clinical signs 
of disease before the study. Cows were housed and fed 
in freestalls, had free access to water, and were milked 
twice daily at 0800 and 1800 h. Cows were fed a TMR 
to provide 100% of NRC requirements daily at 1100 h.
Jugular blood (~150 mL) was collected from each 
cow after the morning milking and before the morn-
ing feeding. Blood was collected into evacuated tubes 
containing acid-citrate dextrose (Fisherbrand, Thermo 
Fisher Scientific Inc., Pittsburgh, PA), inverted to mix, 
and placed on ice. Blood samples were processed within 
1 h of collection.
Isolation of PMNL
Polymorphonuclear leukocytes were isolated accord-
ing to procedures described by Moyes et al. (2009), 
with minor modifications. Blood was transferred to 
15-mL conical tubes (Fisherbrand, Thermo Fisher Sci-
entific Inc.) and centrifuged (model 5810R, Eppendorf, 
Hauppauge, NY) for 20 min at 1,000 × g at 4°C. After 
centrifugation, the plasma, buffy coat, and one-third of 
the red blood cells were discarded. The remaining cells 
were transferred to a 50-mL conical tube (Fisherbrand, 
Thermo Fisher Scientific Inc.), and the cell suspension 
was lysed with 18 mL of ice-cold deionized water. The 
cell suspension was inverted gently for no longer than 
45 s, and isotonicity was restored by addition of 2 mL 
of 10× PBS (pH 7.4; Sigma-Aldrich, St. Louis, MO). 
The solution was then centrifuged for 10 min (200 × g 
at 4°C) and the supernatant decanted. The pellet was 
washed with 20 mL of endotoxin-free, calcium- and 
magnesium-free Hanks’ balanced salt solution (CMF-
HBSS, Sigma-Aldrich) and centrifuged for 5 min (850 
× g at 4°C). If needed, cells were lysed for a second 
time by adding 1.8 mL of ice-cold deionized water fol-
lowed by 200 μL of 10× PBS and 20 mL of CMF-HBSS 
and centrifuged for 5 min (850 × g at 4°C). Cells were 
washed twice with 20 mL of CMF-HBSS and centri-
fuged for 5 min (850 × g at 4°C). After the final wash, 
the pellet was resuspended in 1 mL of CMF-HBSS, 
and PMNL concentrations were measured using a TC-
20 automated cell counter (Bio-Rad Laboratories Inc., 
Hercules, CA). Using the trypan blue (0.1%, Bio-Rad 
Laboratories Inc.) exclusion method (Freshney, 1987), 
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the average viability of PMNL was 92.3%. Cell dif-
ferentials were determined microscopically on cytospin 
preparations using a commercially available hematology 
staining kit (Hema-Fast 3-Step Hematology Staining 
Kit; Fisherbrand, Thermo Fisher Scientific Inc.). Re-
sults indicated that 88.5% of isolated cells were PMNL.
Citrus Essential-Oil Product and Cytotoxicity
Commercially available TCO was obtained from the 
Firmenich Citrus Center (Safety Harbor, FL). Citrus 
essential oils are complex mixtures of volatile (85–99%) 
and nonvolatile compounds (1–15%). The volatile com-
pounds are a mixture of monoterpene and sesquiterpene 
hydrocarbons and their oxygenated derivatives includ-
ing aldehydes, ketones, acids, alcohols, and esters (Fish-
er and Phillips, 2008). Moufida and Marzouk (2003) 
reported that limonene (~88%) is the major component 
of the sweet orange oil, whereas linalool is found in 
minimal proportions (0.02%). However, removal of the 
terpene fraction drastically reduces the proportion of 
limonene (Kirchner and Miller, 1952). Nannapaneni et 
al. (2009) listed linalool (20.2%), decanal (18%), and 
geranial (9.1%) as the main compounds for TCO grown 
in Florida, whereas limonene is only present at 0.3%.
Cytotoxicity. The cytotoxicity of TCO on PMNL 
was determined in vitro. Polymorphonuclear leuko-
cytes (~4 × 104 cells in 200 μL of CMF-HBSS), iso-
lated from 9 cows (134 DIM), were added to a sterile, 
round-bottom, 96-well plate (Fisherbrand, Thermo 
Fisher Scientific Inc.) according to methods previously 
described (Muthaiyan et al., 2012a) with modifications 
for PMNL cytotoxicity. Briefly, plates were centrifuged 
(model 5810R, Eppendorf) at 23°C at 1,000 × g for 
10 min and supernatant was discarded. The pellet was 
resuspended with 200 μL of CMF-HBSS containing a 
fixed amount (0.1%) of dimethyl sulfoxide (DMSO, 
BDH chemicals, VWR International, Philadelphia, PA) 
and either 0, 0.005, 0.01, or 0.1% of TCO. Cells were 
incubated (Binder Inc., Bohemia, NY) at 37°C and 5% 
CO2 for 2 h. Cells were centrifuged at room temperature 
at 1,000 × g for 10 min, and supernatant was discarded 
after centrifugation. Cells were reconstituted again 
with 200 μL of CMF-HBSS and centrifuged at 23°C at 
1,000 × g for 10 min. After centrifugation, cells were re-
suspended in 50 μL of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (5 mg/mL) reconstituted 
in 1× PBS. Cells treated with 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide were incubated 
for 2 h at 37°C and 5% CO2. After incubation, plates 
were centrifuged at 1,000 × g for 10 min, 150 μL of 
DMSO was added to each well, and formed crystals 
were dissolved by vigorously pipetting up and down. 
Finally, plates were incubated at room temperature at 
a constant rotation for 15 min, and absorbance was 
measured at 570 nm. Relative cytotoxicity was calcu-
lated as 1 − (absorbance of treated PMNL/absorbance 
of control PMNL). Supplemental Figure S1 (http://
dx.doi.org/10.3168/jds.2014-8450) depicts the relative 
expression of the different doses of TCO compared 
with the control (0% TCO and 0.1% DMSO). The as-
say demonstrated that 0.01% of TCO or less in 0.1% 
DMSO was not toxic (P > 0.10) to the surveillance of 
PMNL, whereas a dose of 0.1% TCO was toxic (P < 
0.01). Therefore, the dose of 0.01% of TCO in 0.1% 
DMSO was selected for further analysis.
Treatment Preparation. Stock of TCO (commer-
cial product) was diluted at 10% concentration with 
DMSO. A further dilution was performed using CMF-
HBSS to reach a working concentration of 0.1% TCO. 
Incubations were performed in 50-mL conical tubes 
(Fisherbrand, Thermo Fisher Scientific Inc.). Cell sus-
pensions containing 2 × 106 PMNL/mL (phagocytosis 
assay; final volume of 4.0 mL), 6 × 106 PMNL/mL 
(chemotaxis assay; final volume of 1.0 mL), or 6 × 106 
PMNL/mL [quantitative PCR (qPCR); final volume 
of 1.0 mL] were added using RPMI/5% heat-inactivat-
ed fetal bovine serum (FBS; Sigma-Aldrich). For all 
assays, working solutions of either control (0.0% TCO) 
or TCO (0.01% TCO) were added to each tube. All 
PMNL were incubated for 120 min at 37°C, 95% rela-
tive humidity, and 5% CO2 using a constant rotator.
After incubation, PMNL chemotaxis and phago-
cytosis capabilities were assessed as described below. 
For qPCR analysis, 1.0 mL of cell suspensions was 
transferred into 2.0-mL RNase-free tubes (Fisher-
brand, Thermo Fisher Scientific Inc.) and centrifuged 
(10,000 × g at 4°C for 2 min). The spent media were 
collected and stored at −80°C for analysis of tumor 
necrosis factor-α (TNF-α), whereas the cell pellet was 
washed twice with 1.0 mL of 1× PBS and 1.0 mL of 
TRIzol Reagent (Invitrogen, Carlsbad, CA) with 1 μL 
of linear acrylamide (Ambion Inc., Austin, TX) added. 
Polymorphonuclear leukocytes were homogenized (VDI 
25 Homogenizer, VWR International) and stored at 
−80°C until further analysis.
PMNL Chemotaxis
Chemoattractants used in this experiment included 
human IL-8 (Sigma-Aldrich) and recombinant human 
complement 5a (C5a; Sigma-Aldrich). Chemoattrac-
tants were adjusted to a final concentration of 100 ng/
mL and 10−9 M for IL-8 and C5a, respectively, using 1× 
PBS. In triplicate, 600 μL of each chemoattractant was 
added to the bottom wells of a 24-flat bottom well plate 
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(Fisherbrand, Thermo Fisher Scientific Inc.). Filters 
were added (pore size of 5.0 μm; 6.5-mm diameter; 0.3-
cm2 growth area; Fisherbrand, Thermo Fisher Scientific 
Inc.) to the top of each well. A total of 100 μL of cell 
suspension adjusted to 6 × 106 PMNL/mL with RPMI-
1640 (Sigma-Aldrich Co.) containing 5% FBS (Sigma-
Aldrich Co.), and previously incubated with treatments 
(control or TCO), was added to the top of the filter. 
Plates were incubated for 90 min at 37°C, 5.0% CO2, 
and 95% relative humidity. Following incubation, the 
filter was washed vigorously with 200 μL of CMF-HBSS 
twice, and the filter was removed. The total number of 
PMNL migrated was counted using a TC-20 automated 
cell counter (Bio-Rad Laboratories Inc.).
PMNL Phagocytosis
Phagocytosis was performed according to procedures 
described by Moyes et al. (2009). Briefly, before incu-
bation fluorescent beads (Fluoresbrite yellow-green 
Carboxylate 1.75-μm Microspheres; PolySciences, War-
rington, PA) were first precoated with heat-inactivated 
FBS (250 μL of FBS per 1 μL of beads; Sigma-Aldrich 
Co.), and the mixture was protected from the light and 
incubated at room temperature for 45 min. After TCO 
incubation above, 1.0 mL of PMNL (2 × 106) was trans-
ferred into four 5-mL polystyrene round-bottomed tubes 
(Becton Dickinson Labware, Franklin Lakes, NJ). To 
each tube, 100 μL of the FBS-coated beads was added 
to obtain a 10:1 ratio (beads:PMNL). Samples were run 
in duplicate and incubated for 2 h at 37°C, 5% CO2, 
and 95% relative humidity and then centrifuged for 5 
min (1,000 × g at 4°C). The pellets were washed in 1 
mL of CMF-HBSS and fixed with 400 μL of 4% parafor-
maldehyde (Sigma-Aldrich Co.). Samples were stored at 
4°C and protected from light until analysis (~1–2 d) for 
percentage phagocytosis using an XL Flow Cytometer 
(Beckman Coulter, Fullerton, CA). The PMNL popula-
tions were gated by forward scatter and side scatter. 
Data were collected on 20,000 events per sample in the 
gate set for bovine PMNL, and percentage fluorescence 
was used as the quantitative index of PMNL response. 
Phagocytosis by PMNL was expressed as the total per-
centage of PMNL engulfing one or more beads.
71)Į$VVD\
The spent media collected after 2 h incubation of 
PMNL with treatments was analyzed for concentration 
of TNF-α using a bovine-TNF-α commercial kit (Vet-
Set Elisa Development Kit; Kingfisher Biotech Inc., St. 
Paul, MN) following the manufacturer’s protocol. Stan-
dards were prepared with 4% bovine serum albumin in 
PBS, and samples were diluted to 90% concentration 
with the same standard diluents (4% bovine serum 
albumin in PBS). Samples were run in duplicate. The 
intraassay coefficient of variation was 2.1%.
RNA Isolation, cDNA Synthesis, and Quantitative 
Reverse-Transcription PCR (qPCR)
A subset of 6 cows (4 primiparous, 2 multiparous) 
were randomly selected for gene-expression analysis. 
Specific details for total RNA isolation and quality eval-
uation, cDNA synthesis, primer selection and efficiency 
evaluation, and qPCR are found in the Supplemental 
Materials (http://dx.doi.org/10.3168/jds.2014-8450). 
Purity of extracted RNA was calculated by absorbance 
ratio of 260/280 measured using a NanoVue Plus (GE 
Healthcare, Piscataway, NJ) and averaged 1.8. Integrity 
of RNA was measured by the RNA quality indicator 
number using a Experion bioanalyzer (Bio-Rad Labo-
ratories Inc.) and averaged 7.6. Primer sequences and 
accession number are presented in Supplemental Table 
S1 (http://dx.doi.org/10.3168/jds.2014-8450). Primer 
and qPCR validation detailing the slope, intercept, and 
R2 of the dilution curve as well as efficiency are found 
in Supplemental Table S2 (http://dx.doi.org/10.3168/
jds.2014-8450). The quantification-cycle (Cq) values 
from target genes were normalized by the geometric 
mean of 3 (GAPDH, GOLGA5, and OSBPL) out of 
4 candidate target genes that were previously verified 
as suitable reference genes in bovine tissue (Janovick-
Guretzky et al., 2007; Kadegowda et al., 2009; Moyes et 
al., 2010). These 3 reference genes were selected based 
in their lower M value as recommended by the genorm 
analysis (M <0.74) using the Biogazelle q+ software 
(Biogazelle NV, Zwijnaarde, Belgium) and based on 
the work of Vandesompele et al. (2002).
The qPCR results, given as Cq values for each tran-
script, were analyzed using the 2−ΔΔCq method (Livak 
and Schmittgen, 2001). Briefly, the Cq of each target 
gene was calculated and normalized by the geometric 
mean of the 3 selected reference genes to generate delta 
ΔCq values. The ΔCq values of control samples (n = 6) 
were averaged and subtracted from each ΔCq value of 
the TCO samples (n = 6) to generate the ΔΔCq. The 
ΔΔCq values were linearized, to give the fold change 
(FC) value, using the formula 2−ΔΔCq. Then, a posi-
tive and a negative FC value indicate an upregulation 
and downregulation in the mRNA expression of a given 
gene by TCO with respect to control, respectively. Gen-
eral description of the main biological function of the 
analyzed genes can be found in Supplemental Table S3 
(http://dx.doi.org/10.3168/jds.2014-8450).
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Statistical Analysis
Results for the phagocytosis, chemotaxis, and gene 
expression (2−ΔΔCq) assays were log10 transformed for 
statistical analysis. The PROC MIXED procedure of 
SAS (SAS/STAT version 9.2; SAS Institute Inc., Cary, 
NC) was used for statistical analysis. Separation of 
least squares means, for significant effects, was accom-
plished using the Tukey’s option within the MIXED 
procedure of SAS. The main effect of parity and the 
interaction of parity × treatment were not significant 
(P > 0.05) for all variables; therefore, parity was not 
included in the final model. For analysis of cytotoxicity, 
the class variables included cow and treatment (i.e., 
control, 0.05, 0.01, or 0.1% of TCO). For chemotaxis, 
the class variables included cow, treatment (i.e., con-
trol or 0.01% TCO), and chemoattractant (i.e., IL-8 or 
C5a), and the model was run by chemoattractant. For 
phagocytosis, TNF-α, and gene expression, the class 
variables included cow and treatment (i.e., control or 
TCO). The models were used to determine the effect 
of TCO on bovine blood PMNL response in vitro, us-
ing the following statistical model: Yij = μ + Ci + Tj 
+ εij, where Yij is the dependent variable for the ith 
cow for the jth treatment, μ is overall mean, Ci is the 
fixed effect of cow (cow = 1, 2, …, n), Tj is the fixed 
effect of treatment, and εij is the residual error. For all 
models, the degrees of freedom were estimated with 
the Kenward-Roger specification in the model state-
ment. The effect of cow was removed from the model if 
not significant (P > 0.25). Statistical differences were 
declared as significant and highly significant at P < 
0.05 and P < 0.01, respectively. Trends toward sig-
nificance are discussed at 0.05 < P < 0.10. The log10 
least squares means were back-transformed, and data 
are presented as least squares means and confidence 
interval for presentation in tables and figures.
RESULTS AND DISCUSSION
Neutrophils are the most abundant nonspecific leu-
kocytes in blood and are actively recruited to the site 
of infection, such as mammary gland during mastitis 
(Sordillo, 2005). In the healthy mammary gland, the 
most abundant somatic cells are macrophages and lym-
phocytes, with very few PMNL (Kehrli and Shuster, 
1994; Bannantine et al., 2013). However, during mas-
titis, PMNL migrate from the blood to the mammary 
gland and become the predominant somatic cells in 
milk (>95%, Kehrli and Shuster, 1994).
Phagocytosis is one of the hallmarks of PMNL func-
tion, and incubation of PMNL with TCO did not affect 
the ability of PMNL to phagocytose in vitro (14.2 vs. 
15.9% for control and TCO, respectively, Figure 1). 
These results indicate that TCO does not impair PMNL 
function. Recruitment of PMNL to the mammary gland 
initiates a multistep adhesion cascade involving L-selec-
tin coded by the gene SELL in PMNL (Williams et al., 
2011; Mayadas et al., 2014). The migration process of 
PMNL is aided by the orchestrated action of chemoat-
tractants, such as IL-8 and C5a, released by resident 
macrophages and mammary epithelial cells (Burvenich 
et al., 2003; Paape et al., 2003). This migration process, 
also known as chemotaxis, is still not fully understood, 
even though different hypotheses and mechanisms have 
been postulated. Among the most accepted mechanism 
is the hierarchical multistep migration capacity postu-
lated by Foxman et al. (1997) indicating the preference 
of PMNL for end-target chemoattractants such as C5a 
instead of intermediate chemokines such as IL-8. This 
mechanism was complemented recently by Byrne et al. 
(2014) postulating that PMNL can migrate back and 
forth in an oscillatory manner when confronted with 
different chemoattractant signals to finally migrate to 
the sites of infection. Therefore, L-selectin expression is 
influenced by IL-8 and C5a for adherence of PMNL to 
the endothelial wall (Paape et al., 2003). In the current 
study, chemotactic ability of PMNL by IL-8 in vitro 
was improved (P = 0.03) by 47% when PMNL were 
incubated with TCO (Figure 2A), whereas chemotactic 
activity due to C5a did not differ because of treatment 
(Figure 2B). However, expression of SELL was not af-
fected by TCO (FC = −1.20, Table 1). Interestingly, 
expression of IL8 tended (P = 0.08) to be upregulated 
by TCO (FC = 1.93), which may indicate that greater 
expression of IL8 increased the synthesis of IL-8, and 
this enhanced the observed increased chemotaxis ability 
of PMNL incubated with TCO. However, most studies 
evaluating the use of different citrus essential oils (Hi-
rota et al., 2010; Kummer et al., 2013) reported reduc-
tion of migration ability of rodent PMNL in response 
to different chemokines including IL-8. This response 
may be dose dependent where lower concentrations 
do not alter migration of PMNL (Caldefie-Chézet et 
al., 2006; Kacem and Meraihi, 2009). For the current 
study, incubation of PMNL with 0.01% TCO did not 
impair PMNL ability to migrate. Regardless, increased 
expression of IL8 was unexpected based on the down-
regulation of other proinflammatory genes (see below) 
and results from others (Hart et al., 2000; Juergens et 
al., 2004).
Bovine TLR-2 and TLR-4 generally mediate re-
sponses to gram-positive (i.e., Streptococcus spp.) 
and gram-negative (i.e., E. coli) bacteria, respectively 
(Prince et al., 2011). These receptors recognize patho-
gen-associated molecular patterns present on invading 
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microorganisms and can generate a wide range of effects 
on PMNL including migration, activation of signaling 
factors, cytokine production, reactive-oxygen-species 
generation, priming, receptor expression, phagocytosis, 
degranulation, and programmed cell death (Prince et 
al., 2011; Thomas and Schroder, 2013). In the current 
study, expression of TLR4 was not affected by treat-
ment (FC = 1.13), but TLR2 was downregulated in 
PMNL incubated with TCO (FC = −2.14, P = 0.03). 
Smith-Palmer et al. (1998) observed that gram-negative 
bacteria were less susceptible to the microbial effect 
of plant essential oils and hypothesized that the outer 
membrane of gram-negative bacteria is a strong perme-
ability barrier restricting the entry of hydrophobic com-
pounds. Studies at the University of Arkansas using the 
same product as in the current study (TCO) and from 
the same provider reported that 0.1% TCO reduced 
the growth of Staph. aureus (gram positive, Muthaiyan 
et al., 2012b) but failed to inhibit the growth of 11 
serotypes and strains of Salmonella (gram negative) 
when used in 4 serial dilutions starting with 1% TCO 
(O’Bryan et al., 2008). Therefore, TCO may have a 
more potent antimicrobial effect against gram-positive 
bacteria via the downregulation of TLR2 rather than to 
gram-negative bacteria but warrants further investiga-
tion.
The recognition of pathogen-associated molecular 
patterns by TLR-4 present on the surface of PMNL 
elicits a cascade of signaling events that enhance the 
synthesis of proinflammatory cytokines and proinflam-
matory mediators (Prince et al., 2011; Thomas and 
Schroder, 2013). Toll-like receptors activate the NF-κB 
proinflammatory signaling cascade that encompasses 
the activation of MyD88, TRAF-6, IRAK-1, and the 
IKK complex that ultimately leads to secretion of 
proinflammatory cytokines TNF-α, IL-6, and IL-1β 
(Akira et al., 2001). In the current study the expression 
of IRAK1 and TRAF6 was not altered by TCO. To 
the contrary, NFKBIA, the gene coding for the IκBα 
protein, was downregulated by TCO (FC = −1.82, 
P = 0.05). This downregulation would be expected 
considering that NF-κB binds to the IκB promoter to 
activate its transcription; therefore, a decrease in NFK-
BIA expression should be associated with a decrease in 
NF-κB activation, resulting in an overall decrease in 
expression of proinflammatory genes (Camargo et al., 
Figure 1. Percent phagocytosis of PMNL incubated with 0 (con-
trol) or 0.01% of cold-pressed terpeneless orange oil (TCO) in vitro.
Figure 2. Number of PMNL migrating in response to chemokine 
IL-8 (A) and C5a (B) after incubation with either 0 (control) or 0.01% 
of cold-pressed terpeneless orange oil (TCO) in vitro.
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2010). Furthermore, our results showed a downregula-
tion of IL1B (FC = −2.16, P = 0.02) and TNFA (FC 
= −9.43, P < 0.01), encoding for the proinflammatory 
cytokines IL1-β and TNF-α, respectively, and TCO 
did not alter TNF-α production in the spent media of 
PMNL (29.6 vs. 35.3 ± 4.73 pg/μL, TCO and control, 
respectively, P = 0.42). However, these results conflict 
with the downregulation of IL10 (FC = −3.78, P < 
0.01), a known antiinflammatory cytokine. The overall 
downregulation of proinflammatory genes in the cur-
rent study indicates that TCO may have an antiinflam-
matory effect on PMNL transcripts and that TCO does 
not mount a proinflammatory response.
To kill invading microorganisms, PMNL secrete sev-
eral potentially harmful substances during the inflam-
matory response. Among these, the protein lysozyme, 
coded by the gene LYZ, has a strong antimicrobial ef-
fect via degrading the bacteria cell wall (Amulic et al., 
2012). In the current study, expression of LYZ was not 
affected by the incubation of PMNL with TCO. During 
phagocytosis, the reactive oxygen cascade results in the 
production of reactive oxygen species such as superox-
ide anion and H2O2 that aid in the killing of engulfed 
microorganisms (Paape et al., 2003). Superoxide dis-
mutase 2 is an enzyme encoded by SOD2 that converts 
superoxide anion to H2O2 in the mitochondria. In the 
current study, expression of SOD2 tended (P = 0.08) to 
be downregulated in PMNL incubated with TCO (FC 
= −1.57), whereas respiratory burst was not measured. 
Results indicate that TCO does not significantly alter 
transcripts involved in phagocytosis and respiratory 
burst of nonstimulated bovine blood PMNL in vitro.
CONCLUSIONS
Incubation of PMNL with TCO increased chemo-
tactic capability in vitro, whereas PMNL phagocytosis 
was unchanged. The expression of genes involved in 
the proinflammatory response was primarily downregu-
lated; however, TNF-α production was not altered by 
TCO when compared with controls. Results show that 
0.01% TCO does not impair the function of PMNL in 
vitro, indicating that TCO inhibits bacterial growth 
without negatively altering PMNL function. Future 
studies investigating the use of TCO as an alternative 
therapy for treatment of mastitis, including dose and 
duration, for cows during lactation are warranted.
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